Association of Cardiometabolic Disorders with Prostate Cancer Risk: Insights from the PLCO Cancer Screening Study - Takeaways - MDSpire

Association of Cardiometabolic Disorders with Prostate Cancer Risk: Insights from the PLCO Cancer Screening Study

  • By

  • Qian Zhu

  • Lan Zeng

  • Menghui Chen

  • April 29, 2026

  • 0 min

Share

  • 1

    The study analyzed 71,566 participants from the PLCO Cancer Screening Trial to assess the link between cardiometabolic diseases and prostate cancer risk.

  • 2

    Baseline diabetes was associated with an 18% increased risk of developing prostate cancer compared to those without cardiometabolic diseases.

  • 3

    Only the comorbidity of diabetes and heart disease significantly elevated prostate cancer incidence risk among participants with multiple conditions.

  • 4

    Participants with a single cardiometabolic disease had a significantly reduced risk of non-aggressive prostate cancer-specific mortality.

  • 5

    The findings highlight the importance of understanding the interactions between cardiometabolic diseases and prostate cancer for patient management.

Original Source(s)

Association of Cardiometabolic Disorders with Prostate Cancer Risk: Insights from the PLCO Cancer Screening Study

  • by Qian Zhu, Lan Zeng, Menghui Chen

  • April 29, 2026

Related Content

Control Tower in the hospital: a structure–process–outcome systemic review of telemedicine systems for interprofessional collaboration

International Links Between Stressful Life Events in Adulthood and the Development of Heart Disease: A Comprehensive Multicohort Analysis

AI-Selected Trial Candidates are More Diverse

Could artificial intelligence-enabled medical chart review improve the speed, accuracy, and equity of study enrollment?

  • March 10, 2026

  • 3 min